248 related articles for article (PubMed ID: 2076345)
1. Temporal expression of HIV-1 envelope proteins in baculovirus-infected insect cells: implications for glycosylation and CD4 binding.
Murphy CI; Lennick M; Lehar SM; Beltz GA; Young E
Genet Anal Tech Appl; 1990 Oct; 7(6):160-71. PubMed ID: 2076345
[TBL] [Abstract][Full Text] [Related]
2. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
[TBL] [Abstract][Full Text] [Related]
3. Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells.
Wells DE; Compans RW
Virology; 1990 Jun; 176(2):575-86. PubMed ID: 2111957
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.
Gao F; Morrison SG; Robertson DL; Thornton CL; Craig S; Karlsson G; Sodroski J; Morgado M; Galvao-Castro B; von Briesen H; Beddows S; Weber J; Sharp PM; Shaw GM; Hahn BH
J Virol; 1996 Mar; 70(3):1651-67. PubMed ID: 8627686
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
Guo HG; Veronese FM; Tschachler E; Pal R; Kalyanaraman VS; Gallo RC; Reitz MS
Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
[TBL] [Abstract][Full Text] [Related]
6. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
Fenouillet E; Miquelis R; Drillien R
Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
[TBL] [Abstract][Full Text] [Related]
7. Surface expression of the HIV-1 envelope proteins in env gene-transfected CD4-positive human T cell clones: characterization and killing by an antibody-dependent cellular cytotoxic mechanism.
Ahmad A; Yao XA; Tanner JE; Cohen E; Menezes J
J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):789-98. PubMed ID: 7912729
[TBL] [Abstract][Full Text] [Related]
8. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
Bird C; Gleeson PA; Ramsay A; Li P; McCluskey J
AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1999-2009. PubMed ID: 1493050
[TBL] [Abstract][Full Text] [Related]
9. Expression of HIV-1 envelope glycoproteins by Semliki Forest virus vectors.
Paul NL; Marsh M; McKeating JA; Schulz TF; Liljeström P; Garoff H; Weiss RA
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):963-70. PubMed ID: 8280479
[TBL] [Abstract][Full Text] [Related]
10. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity.
Page KA; Stearns SM; Littman DR
J Virol; 1992 Jan; 66(1):524-33. PubMed ID: 1727497
[TBL] [Abstract][Full Text] [Related]
11. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160.
Fenouillet E; Jones IM
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1509-14. PubMed ID: 7782780
[TBL] [Abstract][Full Text] [Related]
12. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
Otteken A; Voss G; Hunsmann G
Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
[TBL] [Abstract][Full Text] [Related]
13. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
Neurath AR; Strick N; Li YY; Jiang S
AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.
Kalyanaraman VS; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico AL; Copeland T; Oroszlan S; Gallo RC; Sarngadharan MG
AIDS Res Hum Retroviruses; 1990 Mar; 6(3):371-80. PubMed ID: 2187500
[TBL] [Abstract][Full Text] [Related]
15. Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
Moore JP; McKeating JA; Jones IM; Stephens PE; Clements G; Thomson S; Weiss RA
AIDS; 1990 Apr; 4(4):307-15. PubMed ID: 2190605
[TBL] [Abstract][Full Text] [Related]
16. Sequences in the rev-responsive element responsible for premature translational arrest in the human-immunodeficiency-virus-type-1 envelope.
Ellerbrok H; Serpente N; Pancino G; Vanhée C; D'Auriol L; Sitbon M; Vaquero C
Eur J Biochem; 1993 Sep; 216(2):459-67. PubMed ID: 8375384
[TBL] [Abstract][Full Text] [Related]
17. Role of HIV-1 envelope V3 loop cleavage in cell tropism.
Gu R; Westervelt P; Ratner L
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1007-15. PubMed ID: 8280475
[TBL] [Abstract][Full Text] [Related]
18. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
Raja NU; Vincent MJ; Jabbar MA
J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
[TBL] [Abstract][Full Text] [Related]
19. Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane.
Jabbar MA; Nayak DP
J Virol; 1990 Dec; 64(12):6297-304. PubMed ID: 2243395
[TBL] [Abstract][Full Text] [Related]
20. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.
Koito A; Harrowe G; Levy JA; Cheng-Mayer C
J Virol; 1994 Apr; 68(4):2253-9. PubMed ID: 8139010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
